Identification of iduronate-2-sulfatase in mouse pancreatic islets

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 5 50-5, 2004, Pages

  Coronado Pons, I ^a   Novials, A ^b   Casas, S ^a,b   Clark, A ^c   Gomis, R ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institute of Diabetes   (Spain)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

cell; Apoptosis; Insulin content and secretion; Islet amyloid polypeptide; Lysosomes; Perlecan

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLYCERALDEHYDE; IDURONATE 2 SULFATASE; INSULIN;

ANIMAL TISSUE; ARTICLE; ELECTRON MICROSCOPY; ENZYME ISOLATION; FLUORESCENCE ACTIVATED CELL SORTING; GLUCOSE METABOLISM; INSULIN RELEASE; LYSOSOME; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CLONE CELLS; GENE EXPRESSION REGULATION; GLUCOSE; HEPARAN SULFATE PROTEOGLYCANS; IDURONATE SULFATASE; ISLETS OF LANGERHANS; LYSOSOMES; MALE; MICE; MICE, INBRED STRAINS; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TISSUE DISTRIBUTION;

EID: 6044228200     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00528.2003     Document Type: Article

References (43)

1. Authier F, Rachubinski RA, Posner BI, and Bergeron JJ. Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. J Biol Chem 269: 3010-3016, 1994.
2. Bhogal RK, Novials A, Nilsson MR, Coronado I, Gomis R, Gray D, Morris JF, and Clark A. Islet amyloid polypeptide (IAPP) accumulates in lysosomes of human beta-cells by crinophagy but does not form fibrils (Abstract). Diabetologia 45, Suppl 2: A144, 2002.
3. Castillo GM, Cummings JA, Yang W, Judge ME, Sheardown MJ, Rimvall K, Hansen JB, and Snow AD. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. Diabetes 47: 612-620, 1998.
4. Chirgwin JM, Przybyla AE, MacDonald RJ, and Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
5. Clark A, de Koning EJP, Baker CA, Chargé S, and Morris JF. Localization of N-terminal pro-islet amyloid polypeptide in beta cells of man and transgenic mice (Abstract). Diabetologia 36: A136, 1993.
6. Conde-Knape K. Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res 17: 412-421, 2001.
7. Cooper CJS, Willis AC, Clark A, Turner RC, Sim RB, and Reid KBM. Purification and characterization of a peptide from amyloid-rich pancreas of type 2 diabetic patients. Proc Natl Acad Sci USA 84: 8628-8631, 1987.
8. Daniele A, Tomanin R, Villani GRD, Zacchello F, Scarpa M, and Di Natale P. Uptake of recombinant iduronate-2-sulfatase into neuronal and glial cells in vitro. Biochim Biophys Acta 1588: 203-209, 2002.
9. De Duve C. The lysosome in retrospect. In: Lysosomes in Biology and Pathology, edited by Dingle JT and Fell HB. Amsterdam: North Holland, 1969, vol. 1, p. 3-40.
10. Dupraz P, Rinsch C, Pralong WF, Rolland E, Zufferey R, Trono D, and Thorens B. Lentivirus-mediated Bcl-2 expression in βTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther 6: 1160-1169, 1999.
11. Ferrer J, Wasson J, Schoor K, Muecker M, Donis-Keller H, and Permutt A. Mapping novel pancreatic islet genes to human chromosomes. Diabetes 46: 386-392, 1997.
12. Flomen RH, Green PM, Bentley DR, and Giannell F. Determination of the organization of coding sequences within the iduronate sulfatase (IDS) gene. Hum Mol Genet 2: 5-10, 1993.
13. Froissart R, Millart G, Mathieu M, Bozon D, and Marie I. Processing of iduronate-2-sulfatase in human fibroblast. Biochem J 309: 425-430, 1995.
14. Gasa R, Gomis R, Casamitjana R, Rivera F, and Novials A. Glucose regulation of islet amyloid polypeptide gene expression in rat pancreatic islets. Am J Physiol Endocrinol Metab 272: E543-E549, 1997.
15. Gebre-Medhin S, Olofsson C, and Mulder H. Islet amyloid polypeptide in the islet of Langerhans: friend or foe? Diabetologia 43: 687-695, 2000.
16. Hart M, Li L, Tokunaga T, Lindsey JR, Hassell JR, Snow AD, and Fukuchi K. Overproduction of perlecan core protein in cultured cells and transgenic mice. J Pathol 194: 262-269, 2001.
17. Hopwood JJ. Enzymes that degrade heparin and heparan sulphate. In: Heparin: Chemical and Biological Properties, Clinical Applications, edited by Lane DW and Lindahl U. London: Arnold, 1989, p. 190-229.
18. Hopwood JJ, Bunge S, Morris CP, Wilson PJ, Steglich C, Beck M, Schwinger E, and Gal A. Molecular basis of mucopolysaccharidosis type II mutations in the iduronate-2-sulphatase gene. Hum Murat 2: 435-442, 1993.
19. Hopwood JJ and Morris CP. The mucopolysaccharidoses: diagnosis, molecular genetics and treatment. Mol Biol Med 7: 381-404, 1990.
20. Kahn SE, Andrikopoulos S, and Verchere CB. Islet amyloid a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48: 241-253, 1999.
21. Kasinath BS, Grellier P, Choudhury GG, and Abboud SL. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium. J Cell Physiol 167: 131-136, 1996.
22. Kisilevsky R and Fraser PE. Ab amyloidogenesis: unique or variation on a systemic theme? Crit Rev Biochem Mol Biol 32: 361-404, 1997.
23. Lacy PE and Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
24. Malmgren H, Carlberg B, Pettersson U, and Bondeson M. Identification of an alternative transcript from the human iduronate-2-sulfatase (IDS) gene. Genomics 29: 291-293, 1995.
25. Millart G, Froissart R, Maire I, and Bozon D. IDS transfer from overexpressing cells to IDS-deficient cells. Exp Cell Res 230: 362-367, 1997.
26. Naldini L, Blomer U, Gage FH, Trono D, and Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93: 11382-11388, 1996.
27. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267, 1996.
28. Neufeld EF and Muenzer J. The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease (8th ed.), edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 2001, p. 3421-3452.
29. Novials A, Sarri Y, Casamitjana R, Rivera F, and Gomis R. Regulation of islet amyloid polypeptide in human pancreatic islets. Diabetes 42: 1514-1519, 1993.
30. Park K and Verchere B. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. J Biol Chem 276: 16611-16616, 2001.
31. Parthasarathy N, Gotow LF, Bottoms JD, Obunike JC, Naggi A, Casu B, Goldberg IJ, and Wagner WD. Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells. Mol Cell Biochem 213: 1-9, 2000.
32. Potter-Perigo S, Hull RL, Tsoi C, Braun KR, Andrikopoulos S, Teague J, Verchere CB, Kahn SE, and Wight TN. Proteoglycans synthesized and secreted by pancreatic islet β-cells bind amylin. Arch Biochem Biophys 413: 182-190, 2003.
33. Rohrbach DH, Hassell JR, Kleinman HK, and Martin GR. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice. Diabetes 31: 185-188, 1982.
34. Schnell AH and Borg LAH. Lysosomes and pancreatic islet function: glucose-dependent alterations of lysosomal morphology. Cell Tissue Res 239: 537-545, 1985.
35. Snow AD and Wight TN. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol Aging 10: 481-497, 1989.
36. Timms KM, Lu F, Shen Y, Pierson CA, Muzny DM, Gu Y, Nelson DL, and Gibbs RA. 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfatase locus. Genome Res 5: 71-78, 1995.
37. Verchere CB, Andrikopoulos S, D'Alessio DA, O'Brien KB, Wight TN, Snow AD, Olin KL, and Khan SE. Role of apolipoprotein E and perlecan in islet amyloid formation in transgenic mice expressing human islet amyloid polypeptide (Abstract). Diabetes 47, Suppl 1: A30, 1998.
38. Watson JD, Lander DA, and Selkoe JD. Heparin binding properties of the amyloidogenic peptides Ab and amylin. J Biol Chem 272: 31317-31624, 1997.
39. Westermark P, Engström U, Westermark GT, Johnson KH, Permerth J, and Betsholtz C. Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diabetes Res Clin Pract 7: 219-226, 1989.
40. Westermark P, Wernstedt C, Wilander E, and Sletten K. A novel peptide in the calcitonin gene-related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140: 827-831, 1986.
41. Wilson PJ, Meaney CA, Hopwood JJ, and Morris CP. Sequence of the human iduronate-2-sulfatase (IDS) gene. Genomics 17: 773-775, 1993.
42. Wilson PJ, Morris CP, Anson DS, Occhodoro T, Bielicki J, Clements PR, and Hopwood JJ. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 87: 8531-8535, 1990.
43. Young DI, Ailles L, Narindrasorasak S, Tan R, and Kisilevsky R. Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposits in type II diabetes mellitus. Arch Pathol Lab Med 116: 951-954, 1992.